Search bioRxiv⌕ Search

Biology subjects

Logsdon, A.

Publications and source records attributed to Logsdon, A..

2 recordsLinked to original sources

AlphaRING: Missense Variant Classification via Protein Modelling and Residue Interaction Network Analysis

BackgroundAccurate interpretation of missense variants remains a significant challenge hindering genomic diagnosis. While state-of-the-art machine learning and deep learning predictors offer high accuracy, they often lack the transparency required for clinical evidence weighting. To bridge this gap between accuracy and clinical utility, we developed AlphaRING-X. MethodsAlphaRING-X is an open-source framework that integrates local and global protein structural stability features using an efficient implementation of gradient boosting, XGBoost, to predict variant deleteriousness. Local stability is interrogated through a combination of AlphaFold-based modelling and residue interaction network analysis. Changes in global stability upon mutation ({Delta}{Delta}G) are estimated using FoldX. For each prediction, AlphaRING-X quantifies the magnitude and direction of each features contribution using Shapley additive explanations (SHAP), providing a unified yet interpretable score. We trained and evaluated the model using a gold standard ClinVar dataset of validated neutral and deleterious variants. ResultsAlphaRING-X achieved an area under the receiver operator curve of 0.94, significantly outperforming widely used predictors such as CADD. Crucially, it provided unambiguous classification for 95.5% of variants at 90% precision in both neutral and deleterious classes. We analysed each predictions SHAP values, identifying local connectivity and disorder as the strongest contributors. ConclusionsAlphaRING-X combines high-performance prediction with the interpretability necessary for clinical decision-making. Its flexible, open-source architecture makes it a powerful, transparent tool for enhancing genomic diagnostics and advancing precision medicine.

bioinformatics↗

The Dynorphin/Kappa Opioid Receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma in male mice

BackgroundAdverse pathophysiological and behavioral outcomes related to mild traumatic brain injury (mTBI), posttraumatic stress disorder (PTSD), and chronic pain are common following blast exposure and contribute to decreased quality of life, but underlying mechanisms and prophylactic/treatment options remain limited. The dynorphin/kappa opioid receptor (KOR) system helps regulate behavioral and inflammatory responses to stress and injury; however, it has yet to be investigated as a potential mechanism in either humans or animals exposed to blast. We hypothesized that blast-induced KOR activation mediates adverse outcomes related to inflammation and affective behavioral response. MethodsC57Bl/6 adult male mice were singly or repeatedly exposed to either sham (anesthesia only) or blast delivered by a pneumatic shock tube. The selective KOR antagonist norBNI or vehicle (saline) was administered 72 hours prior to repetitive blast or sham exposure. Serum and brain were collected 10 minutes or 4 hours post-exposure for dynorphin A-like immunoreactivity and cytokine measurements, respectively. At one-month post-exposure, mice were tested in a series of behavioral assays related to adverse outcomes reported by humans with blast trauma. ResultsRepetitive but not single blast exposure resulted in increased brain dynorphin A-like immunoreactivity. norBNI pretreatment blocked or significantly reduced blast-induced increase in serum and brain cytokines, including IL-6, at 4 hours post exposure and aversive/anxiety-like behavioral dysfunction at one month post exposure. ConclusionsOur findings demonstrate a previously unreported role for the dynorphin/KOR system as a mediator of biochemical and behavioral dysfunction following repetitive blast exposure and highlight this system as a potential prophylactic/therapeutic treatment target.

neuroscience↗